The current status of tuberculosis in Germany and impact of the global situation;Die aktuelle tuberkulosesituation in Deutschland und die auswirkungen der globalen situation

Pneumologie

Volumn 61, Issue 7, 2007, Pages 467-477

  Kunitz, F ^a   Brodhun, B ^b   Hauer, B ^a   Haas, W ^b   Loddenkemper, Robert ^a  

^a HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; DISEASE TRANSMISSION; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MIGRATION; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ADULT; AGE DISTRIBUTION; CHILD; EMIGRATION AND IMMIGRATION; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; WORLD HEALTH;

EID: 34547780479     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-959245     Document Type: Review

References (36)

1. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2002. Robert Koch-Institut Berlin, 2004
2. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2003. Robert Koch-Institut Berlin, 2005
3. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2004. Robert Koch-Institut Berlin, 2006
4. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report. Geneva: World Health Organization (WHO/HTM/TB/2006 362), 2006
5. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1554-1556
6. Cox H, Kebede Y, Allamuratova S et al. Tuberculosis recurrence and mortality after successful treatment: Impact of drug resistance. PLoS Med 2006; 3: e384
7. Cox H, Hargreaves S, Ismailov G. Effect of multidrug resistance on global tuberculosis control. Lancet 2003; 362: 1858-1859
8. Zignol M, Hosseini MS, Wright A et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006; 194: 479-485
9. CDC. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs - worldwide, 2000-2004. Morbidity and Mortality Weekly Report 2006; 55: 301-305
10. Leading Edge. The tuberculosis X factor. Lancet Infect Dis 2006; 6: 679
11. World Health Organisation. Extensively drug-resistant tuberculosis (XDR.TB): Recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-432
12. Raviglione MC, Smith IM. XDR Tuberculosis - Implications for global public health [Perspective]. N Engl J Med 2007; 356: 656-659
13. Khan K, Campbell A, Wallington T et al. The impact of physician training and experience on the survival of patients with active tuberculosis. CMAJ 2006; 175: 749-753
14. Robert Koch-Institut. Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Krankheitserregern. Druckpunkt Berlin: Robert Koch-Institut, 2004
15. Bales S, Baumann HG, Schnitzler N. Infektionsschutzgesetz- Kommentar und Vorschriftensammlung. 2. Aufl. Stuttgart: Kohlhammer, 2003
16. Brodhun B, Kunitz F, Altmann D et al. Epidemiologie der Tuberkulose in Deutschland und weltweit. Pneumologe 2006; 3: 257-265
17. Robert Koch-Institut. Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2001. Berlin: Robert Koch-Institut, 2003
18. Anbieter im Sinne des TDG:Bundesrepublik Deutschland (vertreten durch das Bundesministerium der Justiz): http://www gesetze-im-internet.de/ifsg/index htm. 2006
19. Hillemann D, Kubica T, Rüsch-Gerdes S et al. Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and Non-Beijing strains isolated from Patients in Germany. Antimicrob Agents Chemother 2005; 49: 1229-1231
20. Konietzko N, Loddenkemper R. Tuberkulose. Stuttgart: Georg Thieme Verlag, 1999
21. Brandt HJ, Nörenberg HJ. Besonderheiten der Tuberkulose im Alter. Gerontologie 1997; 10: 433-440
22. Walpola HC, Siskind V, Patel M et al. Tuberculosis-related deaths in Queensland, Australia, 1989-1998: characteristics and risk factors. Int J Tuberc Lung Dis 2006; 7: 742-750
23. Jae Ho Lee, Dae Hee Han, Jae Woo Song, Hee Soon Chung. Diagnostic and therapeutic problems of pulmonary tuberculosis in elderly patients. J Korean Med Sci 2005; 20: 784-791
24. Menon A, Rastogi P, Khadilkar U. Sudden death due to tuberculosis (Case report). Journal of Clinical Forensic Medicine, 2006; (in press)
25. MacGee W. The frequency of unsuspected tuberculosis found post-mortem in a geriatric population. Z Gerontol 1989; 22: 311-314
26. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: WHO/HTM, 2006
27. World Health Organisation. Guidelines for establishing DOTS-Plus pilot projects 2000. WHO/CDS/TB/2000 279, 2000
28. World Health Organiszation. The Stop TB Strategy. Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. WHO/HTM/STB/2006 37, 2006
29. EuroTB. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2004. Report on tuberculosis cases notfied in 2004. Saint-Maurice, France: Institut de Veille Sanitaire, 2006
30. Surucuoglu S, Ozkutuk N, Celik P et al. Drug-resistant pulmonary tuberculosis in western Turkey: prevalence, clinical characteristics and treatment outcome. Ann Saudi Med 2005; 25: 313-318
31. Karabay O, Otkun M, Akata F et al. Antituberculosis drug resistance and associated risk factors in the European section of Turkey. Indian J Chest Dis Allied Sci 2004; 46: 171-172
32. Huong NT, Duong BD, Linh NN et al. Evaluation of sputum smear microscopy in the National Tuberculosis Control Programme in the north of Vietnam. Int J Tuberc Lung Dis 2006; 3: 277-282
33. Perelman MI. Tuberculosis in Russia. 4 (12): 1097-1103. Int J Tuberc Lung Dis 2000; 4: 1097-1103
34. Sagebiel D, Brendel A, Forßbohm M et al. Gefährliche Zunahme mutiresistenter Tuberkulosen in der ehemaligen Sowjetunion. Pneumologie 2002; 56: 1-10
35. World Health Organisation. The Global Plan to Stop TB. WHO/CDS/ STB/2001 16, 2002
36. Paolo WF Jr, Nosanchuk JD. Tuberculosis in New York city: recent lessons and a look ahead. Lancet Infect Dis 2004; 4: 287-293